LISA JESSEE: Open Payments
NPI 1891011235 · WEBER CITY, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$299 in 16 payments from 11 companies in 2025. Trend: 2023 $1,208 · 2024 $1,290 · 2025 $299
Food & beverage: $299
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 3 | $53 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $50 |
| GlaxoSmithKline, LLC. | 2 | $35 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $33 |
| Novo Nordisk Inc | 1 | $22 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $22 |
| PFIZER INC. | 1 | $21 |
| E.R. Squibb & Sons, L.L.C. | 1 | $20 |
| Abbott Laboratories | 1 | $17 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
Products named: MOUNJARO, CAPLYTA, ELIQUIS, TRELEGY ELLIPTA, XIFAXAN, Kerendia, FREESTYLE LIBRE 3, TRINTELLIX.
Industry payments across VA — which companies pay providers there.
